Short Interest in Sartorius (OTCMKTS:SARTF) Drops By 76.3%

Sartorius (OTCMKTS:SARTF) was the target of a large decrease in short interest in May. As of May 29th, there was short interest totaling 579 shares, a decrease of 76.3% from the May 14th total of 2,447 shares. Based on an average daily volume of 53 shares, the days-to-cover ratio is currently 10.9 days. Currently, 0.0% of the company’s shares are sold short.

Sartorius Price Performance

Shares of OTCMKTS SARTF remained flat at $217.65 during midday trading on Friday. Sartorius has a 52-week low of $181.58 and a 52-week high of $227.00. The company has a market capitalization of $7.45 billion, a P/E ratio of 101.23 and a beta of 0.98. The firm’s 50 day moving average price is $218.23 and its 200 day moving average price is $221.29. The company has a debt-to-equity ratio of 0.89, a current ratio of 0.95 and a quick ratio of 0.49.

Sartorius Company Profile

Sartorius AG, trading in the U.S. over the counter under the symbol SARTF, is a Germany-based provider of laboratory and bioprocessing equipment for the pharmaceutical, biotechnology and research industries. The company is organized into two core divisions: Bioprocess Solutions, which focuses on single-use consumables, filtration technologies and upstream and downstream processing systems; and Lab Products & Services, which supplies laboratory instruments, consumables and services, including balances, pipettes, cell counting systems and water purification units.

The Bioprocess Solutions segment serves customers engaged in the development and manufacture of biopharmaceuticals, vaccines and advanced therapies.